Hedge Fund - Perceptive Advisors
Sarepta Therapeutics Inc. (SRPT)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2024 - Q2 (2024-06-30) | $0 | 0% | 0 | $ |
2 | 2024 - Q1 (2024-03-31) | $68,054,921 | 1.19% | 525,683 | $ |
3 | 2023 - Q4 (2023-12-31) | $43,574,113 | 0.97% | 451,873 | $ |
4 | 2023 - Q3 (2023-09-30) | $22,149,318 | 0.73% | 182,720 | $ |
5 | 2023 - Q2 (2023-06-30) | $9,284,594 | 0.26% | 81,074 | $ |
6 | 2023 - Q1 (2023-03-31) | $35,954,058 | 1.06% | 260,858 | $ |
7 | 2022 - Q4 (2022-12-31) | $84,129,815 | 2.36% | 649,250 | $ |
8 | 2022 - Q3 (2022-09-30) | $27,967,000 | 0.81% | 253,000 | $ |
9 | 2017 - Q3 (2017-09-30) | $0 | 0% | 0 | $ |
10 | 2017 - Q2 (2017-06-30) | $36,743,000 | 1.84% | 1,089,961 | $ |
11 | 2017 - Q1 (2017-03-31) | $52,422,000 | 2.98% | 1,771,029 | $ |
12 | 2016 - Q4 (2016-12-31) | $75,976,000 | 5.4% | 2,769,829 | $ |
13 | 2016 - Q3 (2016-09-30) | $208,506,000 | 13.45% | 3,395,236 | $ |
14 | 2016 - Q2 (2016-06-30) | $71,843,000 | 4.98% | 3,767,316 | $ |
15 | 2016 - Q1 (2016-03-31) | $74,823,000 | 6.56% | 3,833,128 | $ |
16 | 2015 - Q4 (2015-12-31) | $86,455,000 | 6.39% | 2,240,928 | $ |
17 | 2015 - Q3 (2015-09-30) | $89,424,000 | 7.14% | 2,784,928 | $ |
18 | 2015 - Q2 (2015-06-30) | $85,494,000 | 5.14% | 2,809,528 | $ |
19 | 2015 - Q1 (2015-03-31) | $29,278,000 | 2.27% | 2,204,652 | $ |
20 | 2014 - Q4 (2014-12-31) | $40,695,000 | 3.41% | 2,812,352 | $ |
21 | 2014 - Q3 (2014-09-30) | $54,790,000 | 5.94% | 2,596,691 | $ |
22 | 2014 - Q2 (2014-06-30) | $76,217,000 | 7.47% | 2,558,478 | $ |
23 | 2014 - Q1 (2014-03-31) | $69,182,000 | 7.26% | 2,878,979 | $ |
24 | 2013 - Q4 (2013-12-31) | $70,981,000 | 8.52% | 3,484,579 | $ |
25 | 2013 - Q3 (2013-09-30) | $130,897,000 | 10.62% | 2,772,069 | $ |
26 | 2013 - Q2 (2013-06-30) | $103,521,000 | 10.43% | 2,722,088 | $ |
27 | 2013 - Q1 (2013-03-31) | $99,269,000 | 11.92% | 2,686,600 | $ |
28 | 2012 - Q4 (2012-12-31) | $33,457,000 | 5.91% | 1,296,800 | $ |
29 | 2012 - Q3 (2012-09-30) | $22,173,000 | 5.05% | 1,427,776 | $ |
The displayed share prices are average quarterly stock market prices.